News
11-02-2011, 06:00 AM
AVEO Pharmaceuticals, Inc. today reported consolidated financial results for the third quarter of 2011 and provided an update on the tivozanib clinical program.
More... (http://www.news-medical.net/news/20111102/AVEO-third-quarter-net-loss-increases-to-24238-million.aspx)
More... (http://www.news-medical.net/news/20111102/AVEO-third-quarter-net-loss-increases-to-24238-million.aspx)